Ora, Inc websites use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and their use, please see our Privacy Policy.
Study testing the effectiveness of an investigational allergy eye drop in reducing eye itching associated with allergies.
Currently Enrolling
This study includes 6 visits over the course of approximately 5-10 weeks.
Clinical study participation includes compensation for every visit.
This study is taking place at clinics throughout the United States.
This study is for children ages 10 and up and adults.
This study is intended for children and adults who have a history of eye allergies (and a positive reaction to an allergy skin test). We are evaluating a potential new combination treatment of two drugs already approved for over-the-counter use in children. Qualified participants will be playing an important role in research and determining the products safety in children.
Key Inclusion Criteria
Key Exclusion Criteria